Pharmaceutical group · United States
Acadia
A group of 5 companies with 8 medicines in 4 countries.
Group structure
5 companies in 1 country
Headquarters not stated2
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine of every company in the group, current ones first.
8 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Daybu 200 mg/ml drankDrank | Trofinetide, Trofinetide x-water | Netherlands | Authorised | 2026 |
| DAYBUE200 mg / ml · Solution | Trofinetide | Canada | Marketed | 2025 |
| DAYBUE200mg/ml · Solution | Trofinetide | United States | Marketed | 2023 |
| DAYBUE STIX10,000mg | 12,000mg · Solution | Trofinetide | United States | Marketed | 2025 |
| DAYBUE STIX5000mg/packet | 6000mg/packet | 8000mg/packet · For solution | Trofinetide | United States | Marketed | 2025 |
| NUPLAZID10MG BASE | 17MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Pimavanserin | United States | Marketed | 2016 |
| NUPLAZID34mg base · Capsule | Pimavanserin | United States | Marketed | 2018 |
| Daybu | Trofinetide | EU (EMA) | pending |